Cadence Verification Platform accelerates debug productivity for Renesas – New Electronics
Cadence Design Systems has announced that Renesas is using the company’s Verisium Artificial Intelligence (AI)-Driven Verification Platform to …
Archive for March, 2023
-
In: DESIGN NEWS
-
In: COPYRIGHT NEWS
[IP China] David Guetta, ChatGPT, AI: Which Copyright In China … – Mondaq News Alerts
[IP China] David Guetta, ChatGPT, AI: Which Copyright In China … Mondaq News Alerts
-
In: DESIGN NEWS
Jamaica’s New Intellectual Property Makeover – Trademark – Mondaq
2020 heralded a new law on patents and designs, with the Patents and … Protocol for the International Registration of Marks (the Protocol).
-
In: PATENT NEWS
The UPC Sunrise Period Has Now Started – Patent – UK – Mondaq News Alerts
The UPC Sunrise Period Has Now Started – Patent – UK Mondaq News Alerts
-
In: COPYRIGHT NEWS
Cracking Down On Preemptive Trademark Registration, Copyright Is … – Mondaq News Alerts
Cracking Down On Preemptive Trademark Registration, Copyright Is … Mondaq News Alerts
-
In: COPYRIGHT NEWS
Discussion On The Legal Requirements For The Protection Of Prior … – Mondaq News Alerts
Discussion On The Legal Requirements For The Protection Of Prior … Mondaq News Alerts
-
In: PATENT NEWS
Green Hydrogen Production Patents: An Analytics Driven Perspective on the Future of … – Lexology
Figure 1: Global Patent Publication Trend in Green Hydrogen Production, 2013-2022. Geographical distribution of green hydrogen patents. In the last …
-
In: PATENT NEWS
The top 10 drugs losing US exclusivity in 2023 – FiercePharma
The top 10 drugs losing US exclusivity in 2023 FiercePharma
-
In: PATENT NEWS
Addressing Legal Issues Related to the Silicon Valley Bank Closure – Wilson Sonsini
On March 10, 2023, Silicon Valley Bank (SVB) was closed by the California Department of Financial Protection & Innovation, with the Federal …
-
In: PATENT NEWS
Third US patent strengthens patent protection for Ascelia Pharma’s Oncoral (daily tablet irinotecan) – Marketscreener.com
Third US patent strengthens patent protection for Ascelia Pharma’s Oncoral (daily tablet irinotecan) Marketscreener.com